Design Therapeutics, Inc. (DSGN) SEC filings
DSGN SEC filings moved a median of +0.21% by the close. DSGN SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the DSGN overview →
47 measured DSGN SEC filing events.
Where these DSGN SEC filings landedvs 47 measured DSGN SEC filing reactions
| Middle 50% of DSGN SEC filing reactions | -3.20% to +4.57% |
|---|---|
| Median reaction (to close) | +0.21% |
| Measured reactions | 47 |
Point-in-time · zero look-ahead
Half of the 47 DSGN SEC filing events with a measured close landed between -3.20% and +4.57%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Design Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -2.91% | +5.98% | |
| Form 8-K Design Therapeutics, For: Aug 03 | SEC filing · Form 8-K | -2.91% | +5.98% | |
| Form 8-K Design Therapeutics, For: Jun 09 | SEC filing · Form 8-K | +0.00% | +4.38% | |
| Form 8-K Design Therapeutics, For: May 18 | SEC filing · Form 8-K | +5.72% | -32.06% | |
| Form 10-Q Design Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +15.69% | +21.46% | |
| Form 8-K Design Therapeutics, For: Apr 28 | SEC filing · Form 8-K | +15.69% | +21.46% | |
| Form ARS Design Therapeutics, For: Dec 31 | SEC filing · Form ARS | -2.47% | -3.32% | |
| Form DEF 14A Design Therapeutics, For: Apr 23 | SEC filing · Form DEF | -2.47% | -3.32% | |
| Form DEFA14A Design Therapeutics, | SEC filing · Form DEFA14A | -2.47% | -3.32% | |
| Form 8-K Design Therapeutics, For: Mar 31 | SEC filing · Form 8-K | +0.74% | +4.17% | |
| Form 10-K Design Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.38% | -5.22% | |
| Form 8-K Design Therapeutics, For: Mar 09 | SEC filing · Form 8-K | +0.38% | -5.22% | |
| Form S-8 Design Therapeutics, | SEC filing · Form S-8 | +0.38% | -5.22% | |
| Form 8-K Design Therapeutics, For: Jan 29 | SEC filing · Form 8-K | +0.59% | +2.56% | |
| Form 10-Q Design Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +6.68% | |
| Form 8-K Design Therapeutics, For: Nov 05 | SEC filing · Form 8-K | +0.00% | +6.68% | |
| Form 8-K Design Therapeutics, For: Sep 09 | SEC filing · Form 8-K | +2.12% | -2.61% | |
| Form 10-Q Design Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.25% | +5.68% | |
| Form 8-K Design Therapeutics, For: Aug 07 | SEC filing · Form 8-K | -0.25% | +5.68% | |
| Form 8-K Design Therapeutics, For: Jun 10 | SEC filing · Form 8-K | -1.45% | +1.32% | |
| Form EFFECT Design Therapeutics, | SEC filing · Form EFFECT | +0.00% | +2.92% | |
| Form 10-Q Design Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +1.51% | +6.67% | |
| Form 8-K Design Therapeutics, For: May 07 | SEC filing · Form 8-K | +1.51% | +6.67% | |
| Form S-3 Design Therapeutics, | SEC filing · Form S-3 | +1.51% | +6.67% | |
| Form DEFR14A Design Therapeutics, | SEC filing · Form DEFR14A | -8.13% | -3.09% | |
| Form ARS Design Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.24% | -7.40% | |
| Form DEF 14A Design Therapeutics, For: Jun 10 | SEC filing · Form DEF | +0.24% | -7.40% | |
| Form DEFA14A Design Therapeutics, | SEC filing · Form DEFA14A | +0.24% | -7.40% | |
| Form 10-K Design Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.31% | +0.00% | |
| Form 8-K Design Therapeutics, For: Mar 10 | SEC filing · Form 8-K | +0.31% | +0.00% | |
| Form S-8 Design Therapeutics, | SEC filing · Form S-8 | +0.31% | +0.00% | |
| Form 8-K Design Therapeutics, For: Jan 13 | SEC filing · Form 8-K | -5.43% | -7.96% | |
| Form 10-Q Design Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +1.04% | |
| Form 8-K Design Therapeutics, For: Nov 07 | SEC filing · Form 8-K | +0.00% | +1.04% | |
| Form 10-Q Design Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.11% | -0.64% | |
| Form 8-K Design Therapeutics, For: Aug 05 | SEC filing · Form 8-K | +0.11% | -0.64% | |
| Form 8-K Design Therapeutics, For: Jun 13 | SEC filing · Form 8-K | +0.26% | -7.33% | |
| Form 10-Q Design Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.38% | +0.21% | |
| Form 8-K Design Therapeutics, For: May 08 | SEC filing · Form 8-K | -0.38% | +0.21% | |
| Form ARS Design Therapeutics, For: Dec 31 | SEC filing · Form ARS | -1.99% | +0.27% | |
| Form DEF 14A Design Therapeutics, For: Jun 13 | SEC filing · Form DEF | -1.99% | +0.27% | |
| Form DEFA14A Design Therapeutics, | SEC filing · Form DEFA14A | -1.99% | +0.27% | |
| Form 10-K Design Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -11.34% | -0.34% | |
| Form 8-K Design Therapeutics, For: Mar 19 | SEC filing · Form 8-K | -11.34% | -0.34% | |
| Form S-8 Design Therapeutics, | SEC filing · Form S-8 | -11.34% | -0.34% | |
| Form 10-Q Design Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.69% | +4.57% | |
| Form 8-K Design Therapeutics, For: Nov 13 | SEC filing · Form 8-K | +0.69% | +4.57% |
Keep exploring
More DSGN: earnings → · analyst actions → · DSGN overview →